Clinical Trial Update: An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Open-label Phase 1 study of CND261 in seropositive rheumatoid arthritis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CND261

Snippet

Sponsor: Candid Therapeutics | Conditions: Rheumatoid Arthritis | Phase 1 | Status: ACTIVE_NOT_RECRUITING